Access Regimes and Intellectual Property Rights: Exploring the Interface for Drug Research

Abstract

"Advancing the discussion on the interface between access regimes and intellectual property rights requires focus on questions of legal and institutional design at the national level, and calls for positioning of bioprospecting strategically within broader challenges in the area of intellectual property protection, drug R&D, and public health."